Explore All 3115 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 9, 2009 |
| Target | PLIVA HRVATSKA d.o.o. |
| Sector | Life Science |
| Buyer(s) | Teva Pharmaceutical Industries |
| Deal Type | Add-on Acquisition |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1901 |
| Sector | Life Science |
| Employees | 37,000 |
| Revenue | 16.5B USD (2024) |
Teva Pharmaceutical Industries is a provider of pharmaceutical products, committed to increasing access to high-quality healthcare by developing, producing, and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Teva Pharmaceutical Industries was founded in 1901 and is based in Tel Aviv, Israel.
| Deal Context for Buyer | # |
|---|---|
| Overall | 9 of 23 |
| Sector: Life Science | 8 of 20 |
| Type: Add-on Acquisition | 8 of 19 |
| Country: Croatia | 1 of 1 |
| Year: 2009 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-12-23 |
Barr Pharmaceuticals
Montvale, New Jersey, United States Barr Pharmaceuticals, Inc. manufactures generic and proprietary pharmaceuticals in US. |
Buy | $7.5B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-03-18 |
ratiopharm
Ulm, Germany ratiopharm GmbH is a developer, manufacturer, distributor, and sells generic medicines and biopharmaceuticals. |
Buy | €3.6B |
